IMAX Stock Price, News & Analysis (NYSE:IMAX)

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for IMAX in the last year. There are currently 1 sell rating, 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" IMAX shares.
View IMAX analyst ratings or view top-rated stocks.

8 brokerages have issued 1-year price objectives for IMAX's shares. Their IMAX share price targets range from $14.00 to $30.00. On average, they expect the company's stock price to reach $23.43 in the next twelve months. This suggests a possible upside of 49.2% from the stock's current price.
View analysts price targets for IMAX or view top-rated stocks among Wall Street analysts.

IMAX's stock was trading at $14.66 at the start of the year. Since then, IMAX stock has increased by 7.1% and is now trading at $15.70.
View the best growth stocks for 2023 here.

IMAX saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 3,690,000 shares, an increase of 21.0% from the October 31st total of 3,050,000 shares. Based on an average daily trading volume, of 563,400 shares, the short-interest ratio is presently 6.5 days. Currently, 8.3% of the company's shares are sold short.
View IMAX's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 28th 2024.
View our IMAX earnings forecast.

IMAX Co. (NYSE:IMAX) posted its quarterly earnings data on Wednesday, October, 25th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.15. The firm earned $103.90 million during the quarter, compared to analyst estimates of $97.16 million. IMAX had a trailing twelve-month return on equity of 9.21% and a net margin of 6.57%.

Innovator IBD Breakout Opportunities ETF holds 16,512 shares of IMAX stock, representing 2.33% of its portfolio.

36 employees have rated IMAX Chief Executive Officer Richard L. Gelfond on Glassdoor.com. Richard L. Gelfond has an approval rating of 63% among the company's employees. This puts Richard L. Gelfond in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other IMAX investors own include Stillwater Mining (SWC), Integrated Device Technology (IDTI), Turquoise Hill Resources (TRQ), Skyworks Solutions (SWKS), Progenics Pharmaceuticals (PGNX), InvenSense (INVN), Walt Disney (DIS), Intel (INTC), Tesla (TSLA) and Gilead Sciences (GILD).

IMAX's stock is owned by a variety of retail and institutional investors. Top institutional investors include FMR LLC (4.73%), Invesco Ltd. (4.67%), Primecap Management Co. CA (1.92%), Private Capital Management LLC (1.41%), Bank of New York Mellon Corp (1.36%) and Victory Capital Management Inc. (1.34%). Insiders that own company stock include Calamera Pablo, Denny Tu, Jacqueline Bassani, Kenneth Ian Weissman, Mark Welton, Megan Colligan and Richard L Gelfond.
View institutional ownership trends.

Shares of IMAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.